BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17530640)

  • 21. Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.
    Kocheril SV; Appleton BE; Somers EC; Kazerooni EA; Flaherty KR; Martinez FJ; Gross BH; Crofford LJ
    Arthritis Rheum; 2005 Aug; 53(4):549-57. PubMed ID: 16082627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF; Pope JE; Ouimet JM
    Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchoalveolar matrix metalloproteinase 9 relates to restrictive lung function impairment in systemic sclerosis.
    Andersen GN; Nilsson K; Pourazar J; Hackett TL; Kazzam E; Blomberg A; Waldenström A; Warner J; Rantapää-Dahlqvist S; Mincheva-Nilsson L; Sandström T
    Respir Med; 2007 Oct; 101(10):2199-206. PubMed ID: 17643278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of ab initio immunosuppressive therapy and steroid-sparing effect in interstitial lung disease associated with antisynthetase antibody syndrome].
    Franzolini N; Quartuccio L; De Marchi G; De Vita S
    Reumatismo; 2007; 59(3):202-8. PubMed ID: 17898879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study.
    Wanchu A; Suryanaryana BS; Sharma S; Sharma A; Bambery P
    Int J Rheum Dis; 2009 Sep; 12(3):239-42. PubMed ID: 20374353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease: prospective study of a cohort of 562 patients].
    Jara-Palomares L; Martín-Juan J; Gómez-Izquierdo L; Cayuela-Domínguez A; Rodríguez-Becerra E; Rodríguez-Panadero F
    Arch Bronconeumol; 2009 Mar; 45(3):111-7. PubMed ID: 19286112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
    De Santis M; Bosello SL; Peluso G; Pinnelli M; Alivernini S; Zizzo G; Bocci M; Capacci A; La Torre G; Mannocci A; Pagliari G; Varone F; Pistelli R; Danza FM; Ferraccioli G
    Clin Respir J; 2012 Jan; 6(1):9-17. PubMed ID: 21801327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
    Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
    Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.
    Le Pavec J; Girgis RE; Lechtzin N; Mathai SC; Launay D; Hummers LK; Zaiman A; Sitbon O; Simonneau G; Humbert M; Hassoun PM
    Arthritis Rheum; 2011 Aug; 63(8):2456-64. PubMed ID: 21538327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
    Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
    J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bronchoalveolar lavage in idiopathic interstitial lung diseases.
    Nagai S; Handa T; Ito Y; Takeuchi M; Izumi T
    Semin Respir Crit Care Med; 2007 Oct; 28(5):496-503. PubMed ID: 17975777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis.
    Beretta L; Santaniello A; Lemos A; Masciocchi M; Scorza R
    Rheumatology (Oxford); 2007 Feb; 46(2):296-301. PubMed ID: 16877463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytologic findings].
    Salaffi F; Carotti M; Baldelli S; Bichi Secchi E; Manganelli P; Subiaco S; Salvolini L
    Radiol Med; 1999; 97(1-2):33-41. PubMed ID: 10319097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Present status of bronchoalveolar lavage in interstitial lung disease.
    Reynolds HY
    Curr Opin Pulm Med; 2009 Sep; 15(5):479-85. PubMed ID: 19636227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
    J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parenchymal and vascular interactions in the pathogenesis of nonspecific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia.
    Franco de Carvalho E; Parra ER; de Souza R; Muxfeldt A'b Saber A; Capelozzi VL
    Respiration; 2008; 76(2):146-53. PubMed ID: 18073456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.
    Moore OA; Goh N; Corte T; Rouse H; Hennessy O; Thakkar V; Byron J; Sahhar J; Roddy J; Gabbay E; Youssef P; Nash P; Zochling J; Proudman SM; Stevens W; Nikpour M
    Rheumatology (Oxford); 2013 Jan; 52(1):155-60. PubMed ID: 23065360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.